I am a
Home I AM A Search Login

Papers of the Week


Papers: 24 Apr 2021 - 30 Apr 2021


Human Studies, Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2021 Apr 28


Neurology

Long-Term Efficacy and Safety of Erenumab: Results From 64 Weeks of the LIBERTY Study.

Authors

Goadsby PJ, Reuter U, Lanteri-Minet M, Paiva da Silva Lima G, Hours-Zesiger P, Fernandes C, Wen S, Tenenbaum N, Kataria A, Ferrari MD, Klatt J
Neurology. 2021 Apr 28.
PMID: 33910942.

Abstract

To report the efficacy and safety of erenumab among episodic migraine (EM) patients who were unsuccessful on 2-4 preventive treatments observed at week 64 of Open-Label Extension Phase (OLEP) of the LIBERTY study (ClinicalTrials.gov NCT03096834).